Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement From the American Heart Association
Baddour LM, Weimer MB, Wurcel AG, McElhinney DB, Marks LR, Fanucchi LC, Garrigos Z, Pettersson GB, DeSimone DC, Fever E. Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement From the American Heart Association. Circulation 2022, 146: e187-e201. PMID: 36043414, DOI: 10.1161/cir.0000000000001090.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAmerican Heart AssociationInfective endocarditisHeart AssociationScientific statementInjection drug useAspects of careInfective endocarditis casesEnglish-language articlesRemoval of duplicatesEndocarditis teamVariety of specialistsEndocarditis casesCardiovascular surgeryIncreasing incidenceSubsequent boutEndocarditisHigh riskInitial boutDrug useInfectious diseasesAddiction medicineLiterature searchPreventive measuresUnique populationDrugsInfectious Complications of Injection Drug Use
Marks LR, Nolan NS, Liang SY, Durkin MJ, Weimer MB. Infectious Complications of Injection Drug Use. Medical Clinics Of North America 2022, 106: 187-200. PMID: 34823730, DOI: 10.1016/j.mcna.2021.08.006.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsInjection drug useInjection drug use-related infective endocarditisHuman immunodeficiency virusHepatitis C virusInfectious complicationsDrug useCommon infectious complicationOpioid use disorderCommon risk factorsCause of deathOpioid overdose epidemicViral hepatitisInfective endocarditisImmunodeficiency virusClinical syndromeHIV outbreakInfectious disease epidemicsC virusRisk factorsIntravenous administrationOverdose epidemicUse disordersModel of treatmentMedical careInfectious diseases